Literature DB >> 36268104

Quantitative Nuclear Histomorphometry Predicts Molecular Subtype and Clinical Outcome in Medulloblastomas: Preliminary Findings.

Jon Whitney1, Liisa Dollinger2, Benita Tamrazi3, Debra Hawes4, Marta Couce5, Julia Marcheque6, Alexander Judkins4, Ashley Margol7, Anant Madabhushi8,9.   

Abstract

Molecular subtypes of medulloblastoma [Sonic Hedgehog (SHH), Wingless/INT (WNT), Group 3, and Group 4] are defined by common patterns of gene expression. These differential gene expression patterns appear to result in different histomorphology and prognosis. Quantitative histomorphometry is a well-known method of computer-aided pathology image analysis. The hypotheses we sought to examine in this preliminary proof of concept study were whether computer extracted nuclear morphological features of medulloblastomas from digitized tissue slide images could independently: (1) distinguish between molecularly determined subgroups and (2) identify patterns within these subgroups that correspond with clinical outcome. Our dataset was composed of 46 medulloblastoma patients: 16 SHH (5 dead, 11 survived), 3 WNT (0 dead, 3 survived), 12 Group 3 (4 dead, 8 survived), and 15 were Group 4 (5 dead, 10 survived). A watershed-based thresholding scheme was used to automatically identify individual nuclei within digitized whole slide hematoxylin and eosin tissue images. Quantitative histomorphometric features corresponding to the texture (variation in pixel intensity), shape (variations in size, roundness), and architectural rearrangement (distances between, and number of connected neighbors) of nuclei were subsequently extracted. These features were ranked using feature selection schemes and these top-ranked features were then used to train machine-learning classifiers via threefold cross-validation to separate patients based on: (1) molecular subtype and (2) disease-specific outcomes within the individual molecular subtype groups. SHH and WNT tumors were separated from Groups 3 and 4 tumors with a maximum area under the receiver operating characteristic curve (AUC) of 0.7, survival within Group 3 tumors was predicted with an AUC of 0.92, and Group 3 and 4 patients were separated into high- and low-risk groups with p = 0.002. Model prediction was quantitatively compared with age, stage, and histological subtype using univariate and multivariate Cox hazard ratio models. Age was the most statistically significant variable for predicting survival in Group 3 and 4 tumors, but model predictions had the highest hazard ratio value. Quantitative nuclear histomorphometry can be used to study medulloblastoma genetic expression phenotypes as it may distinguish meaningful features of disease pathology.
© 2022 The Authors.

Entities:  

Year:  2022        PMID: 36268104      PMCID: PMC9576985          DOI: 10.1016/j.jpi.2022.100090

Source DB:  PubMed          Journal:  J Pathol Inform


  34 in total

1.  Stratification of medulloblastoma on the basis of histopathological grading.

Authors:  Felice Giangaspero; Stefan Wellek; Jun Masuoka; Marco Gessi; Paul Kleihues; Hiroko Ohgaki
Journal:  Acta Neuropathol       Date:  2006-04-29       Impact factor: 17.088

2.  Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease.

Authors:  T J MacDonald; K M Brown; B LaFleur; K Peterson; C Lawlor; Y Chen; R J Packer; P Cogen; D A Stephan
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

3.  Medulloblastoma comprises four distinct molecular variants.

Authors:  Paul A Northcott; Andrey Korshunov; Hendrik Witt; Thomas Hielscher; Charles G Eberhart; Stephen Mack; Eric Bouffet; Steven C Clifford; Cynthia E Hawkins; Pim French; James T Rutka; Stefan Pfister; Michael D Taylor
Journal:  J Clin Oncol       Date:  2010-09-07       Impact factor: 44.544

4.  Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients.

Authors:  Jayne M Lamont; Charles S McManamy; Andrew D Pearson; Steven C Clifford; David W Ellison
Journal:  Clin Cancer Res       Date:  2004-08-15       Impact factor: 12.531

5.  Heterozygosity for Pten promotes tumorigenesis in a mouse model of medulloblastoma.

Authors:  Robert C Castellino; Benjamin G Barwick; Matthew Schniederjan; Meghan C Buss; Oren Becher; Dolores Hambardzumyan; Tobey J Macdonald; Daniel J Brat; Donald L Durden
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

6.  A visual latent semantic approach for automatic analysis and interpretation of anaplastic medulloblastoma virtual slides.

Authors:  Angel Cruz-Roa; Fabio González; Joseph Galaro; Alexander R Judkins; David Ellison; Jennifer Baccon; Anant Madabhushi; Eduardo Romero
Journal:  Med Image Comput Comput Assist Interv       Date:  2012

7.  Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics.

Authors:  Sarah Fattet; Christine Haberler; Patricia Legoix; Pascale Varlet; Arielle Lellouch-Tubiana; Severine Lair; Elodie Manie; Marie-Anne Raquin; Danielle Bours; Sabrina Carpentier; Emmanuel Barillot; Jacques Grill; Francois Doz; Stephanie Puget; Isabelle Janoueix-Lerosey; Olivier Delattre
Journal:  J Pathol       Date:  2009-05       Impact factor: 7.996

8.  Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study.

Authors:  L L Wang; R Teshiba; N Ikegaki; X X Tang; A Naranjo; W B London; M D Hogarty; J M Gastier-Foster; A T Look; J R Park; J M Maris; S L Cohn; R C Seeger; S Asgharzadeh; H Shimada
Journal:  Br J Cancer       Date:  2015-06-02       Impact factor: 7.640

9.  Prognostic classification of early ovarian cancer based on very low dimensionality adaptive texture feature vectors from cell nuclei from monolayers and histological sections.

Authors:  B Nielsen; F Albregtsen; W Kildal; H E Danielsen
Journal:  Anal Cell Pathol       Date:  2001       Impact factor: 2.916

10.  Automatic nuclei segmentation in H&E stained breast cancer histopathology images.

Authors:  Mitko Veta; Paul J van Diest; Robert Kornegoor; André Huisman; Max A Viergever; Josien P W Pluim
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.